OTC - ACTIVE INGREDIENT SECTION
Active Ingredients: ZINC OXIDE, TITANIUM DIOXIDE
Active Ingredients: ZINC OXIDE, TITANIUM DIOXIDE
Inactive Ingredients:
HOUTTUYNIA CORDATA EXTRACT, PLANTAGO ASIATICA EXTRACT, GLECHOMA HEDERACEA FLOWER/LEAF/STEM EXTRACT, MORUS ALBA LEAF EXTRACT, ULMUS DAVIDIANA ROOT EXTRACT, CYCLOPENTASILOXANE, SQUALANE, PEG-10 DIMETHICONE, METHICONE COPOLYMER, DIPROPYLENE GLYCOL, BUTYLENE GLYCOL, VINYL DIMETHICONE CROSSPOLYMER, DIMETHICONE, ALUMINUM HYDROXIDE, STEARIC ACID, SODIUM CHLORIDE, BETAINE, DISTEARYLDIMONIUM CHLORIDE, BENTONITE, CAPRYLYL GLYCOL, CAPRYLHYDROXAMIC ACID, GLYCERIN, BETA-GLUCAN, PANTHENOL, TOCOPHERYL ACETATE, FRAGRANCE, CERAMIDE 3
Directions:
It is good to use within 3minute after bath and use it like you are massaging the skin if the child scratches or on a dry day.
Caution:
For external use only.
Use only as directed.
Do not apply to sensitive skin.
Keep out of reach of children.
Store in a cool. dry place.
| Class | Version | Type | Effective |
|---|---|---|---|
| ZINC CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 75885-010-01 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-d20b-8e05-e053-dbdaa90a074a | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 75885-010-01 | PUTTO ATO SECRET UV FACESPF 6 | 80 mL in 1 CARTON | CREAM | 80 | 3 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 3 | |
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | 3 | |
| TITANIUM | ACTIVE MOIETY | D1JT611TNE | 3 | |
| ZINC CATION | ACTIVE MOIETY | 13S1S8SF37 | 3 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 3 | |
| DIPROPYLENE GLYCOL | INACTIVE INGREDIENT | E107L85C40 | 3 | |
| GLECHOMA HEDERACEA | INACTIVE INGREDIENT | L6O7WQK912 | 3 | |
| PLANTAGO MAJOR | INACTIVE INGREDIENT | W2469WNO6U | 3 | |
| SQUALANE | INACTIVE INGREDIENT | GW89575KF9 | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 75885-010 | 75885-010-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ZINC OXIDE | SOI2LOH54Z | ACTIB |
| TITANIUM DIOXIDE | 15FIX9V2JP | ACTIB |
| PLANTAGO MAJOR | W2469WNO6U | IACT |
| GLECHOMA HEDERACEA | L6O7WQK912 | IACT |
| SQUALANE | GW89575KF9 | IACT |
| DIPROPYLENE GLYCOL | E107L85C40 | IACT |
| BUTYLENE GLYCOL | 3XUS85K0RA | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TRANSDERMAL | 8.12 mg | ||
| DIPROPYLENE GLYCOL | DIPROPYLENE GLYCOL | E107L85C40 | FILM, EXTENDED RELEASE / BUCCAL | 30 mg | ||
| DIPROPYLENE GLYCOL | DIPROPYLENE GLYCOL | E107L85C40 | SYSTEM / TRANSDERMAL | 6 mg | ||
| SQUALANE | SQUALANE | GW89575KF9 | POWDER / ORAL | 0.02 mg | ||
| SQUALANE | SQUALANE | GW89575KF9 | SOLUTION / TOPICAL | 1 %w/w | ||
| SQUALANE | SQUALANE | GW89575KF9 | CREAM, AUGMENTED / TOPICAL | 120 mg | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| SQUALANE | SQUALANE | GW89575KF9 | CREAM / TOPICAL | 6 %w/w | ||
| SQUALANE | SQUALANE | GW89575KF9 | AEROSOL, FOAM / TOPICAL | 2.23 %w/w | ||
| DIPROPYLENE GLYCOL | DIPROPYLENE GLYCOL | E107L85C40 | FILM, EXTENDED RELEASE / TRANSDERMAL | 296 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| cd93b0ad-b8ec-455c-a530-9735905b1d51 | eaf411f4-4332-4868-b10c-b084b555c3b8 | 2011-02-17 | cd93b0ad-b8ec-455c-a530-9735905b1d51 eaf411f4-4332-4868-b10c-b084b555c3b8 |
Adverse event summaries are temporarily unavailable. Other product information remains available.